Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04458948 · ClinicalTrials.gov registry record · Phase 2
Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients
A Phase 2 study, sponsored by University of New Mexico.
- Terminated
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT04458948: Clinical Trial Phase 2 study, sponsored by University of New Mexico.
NCT04458948 is a Phase 2 study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 28 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04458948, a Phase 2 study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
This research is designed as an open-label,non-comparative prospective trial.
Primary Outcome
To measure the duration of viral shedding in respiratory secretions of patients with moderate to severe COVID-19 infection treated with the combination of Hydroxychloroquine and azithromycin.
Interventions
- DRUG Azithromycin
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-03-24 |
| Est. Completion | 2020-08-28 |
| Phase | Phase 2 |
Why NCT04458948 stopped before completion
NCT04458948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Azithromycin is the first listed.
NCT04458948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04458948 about?
NCT04458948 is a clinical study titled "Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients". This research is designed as an open-label,non-comparative prospective trial.
What is the current status of trial NCT04458948?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2020-03-24. Estimated completion is 2020-08-28.
What interventions are being tested in trial NCT04458948?
The interventions under investigation include: Azithromycin (DRUG), Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT04458948?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04458948's enrollment target sits among peer trials
28 1677th of 2000 higher than 304 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI